INSPUR DIGI ENT (00596) saw its shares rise more than 20% in late trading. At the time of writing, the stock was up 20.37%, trading at HK$2.6, with a turnover of HK$55.9527 million.

The surge follows the company's 2026 INSPUR DIGI ENT Innovation Summit held in Beijing on April 17. During the event, INSPUR DIGI ENT officially launched its Haiyue Enterprise AI Native Product System. This represents a new generation of the company's research and development framework, encompassing core products such as Commercial AI 2.0, Industrial AI 1.0, an enterprise-grade agent platform, an ontology twin platform, and a new intelligent-native UI.

Kaiyuan Securities noted that the company's AI business development is already yielding results. For 2026, the company is committed to its "1321" business development strategy, targeting 100% growth in AI business revenue and a 50% increase in intelligent computing center revenue. Leveraging the Haiyue large model, INSPUR DIGI ENT is progressively advancing its AI business upgrades. The company has already accumulated successful use cases, including intelligent finance and business integration, smart audit and collaboration, and intelligent control fusion in the salt chemical industry. The number of intelligent agents has grown from over 100 to more than 300, and the number of covered scenarios has increased from over 60 to more than 100.